We are live on ! Find out more
FCMI

Foresite Capital Management I Portfolio holdings

AUM $21.4M
1-Year Est. Return 80.48%
This Fund
S&P 500
This Quarter Est. Return
+20.55%
1 Year Est. Return
-80.48%
3 Year Est. Return
-40.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
+$39.4M
Cap. Flow
+$16M
Cap. Flow %
11.24%
Top 10 Hldgs %
99.49%
Holding
12
New
3
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
OREX
Orexigen Therapeutics, Inc.
OREX
+$8.45M
2
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$5.65M
3
RXDX
Ignyta, Inc.
RXDX
+$4.68M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 86.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KPTI icon
1
Karyopharm Therapeutics
KPTI
$216M
$49M 34.41%
105,716
– –
KERX
2
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$22.4M 15.71%
1,312,006
– –
AMBI
3
DELISTED
Ambit Biosciences Corp
AMBI
$19M 13.32%
2,079,569
– –
TLPH icon
4
Talphera
TLPH
$68.5M
$16.6M 11.64%
68,954
– –
XNCR icon
5
Xencor
XNCR
$1.3B
$9.62M 6.76%
820,000
– –
OREX
6
DELISTED
Orexigen Therapeutics, Inc.
OREX
$8.13M 5.71%
+125,000
New +$8.45M
NVAX icon
7
Novavax
NVAX
$1.35B
$6.05M 4.25%
66,810
– –
BDSI
8
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$5.91M 4.15%
+700,000
New +$5.65M
RXDX
9
DELISTED
Ignyta, Inc.
RXDX
$4.15M 2.92%
+500,000
New +$4.68M
NVAX icon
10
PUT
Novavax
NVAX
$1.35B
$906K 0.64%
100
-225
-69% -$25.1K
XLRN
11
DELISTED
Acceleron Pharma
XLRN
$721K 0.51%
20,892
-45,108
-68% -$2.04M
BDSI
12
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-2,000
Closed -$720K

Similar funds

A
Atlassian San Francisco, California $21M AUM 71.86% 1-Year Est. Return
CVGI
Craft Ventures GP II San Francisco, California $24.1M AUM 83.06% 1-Year Est. Return
AEPI
AH Equity Partners IV Menlo Park, California $24.5M AUM 73.4% 1-Year Est. Return
AGDR
AdamCapital Gestao de Recursos Rio De Janeiro, Brazil $18.1M AUM 32.38% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
WL
WiL LLC Palo Alto, California $17.5M AUM 75.04% 1-Year Est. Return
NVPX
Norwest Venture Partners XIII Palo Alto, California $25.8M AUM 76.52% 1-Year Est. Return
SVGI
Sozo Ventures GP I Redwood City, California $16.3M AUM 66.18% 1-Year Est. Return

Foresite Capital Management I's Q1 2014 Portfolio in Review

As of Q1 2014, Foresite Capital Management I held 12 positions worth $142M, up 38% from $103M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Foresite Capital Management I deployed $16M of net new capital in Q1 2014, opening 3 new positions. Its largest new stake was Orexigen Therapeutics, Inc.: 125,000 shares worth $8.13M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 80% a quarter earlier.

On the sell side, the largest reduction was Acceleron Pharma, an estimated $2.04M trimmed.

  • Foresite Capital Management I's largest Q1 2014 buy was Orexigen Therapeutics, Inc.: 125,000 shares worth $8.13M.
  • Foresite Capital Management I's biggest Q1 2014 reduction was Acceleron Pharma, cutting an estimated $2.04M.
  • Foresite Capital Management I's ten largest holdings make up 99% of its $142M portfolio in Q1 2014.
  • Foresite Capital Management I opened 3 new positions and closed 1 in Q1 2014.
  • Foresite Capital Management I's portfolio value rose 38% quarter-over-quarter to $142M.

Based on Foresite Capital Management I's 13F filing for Q1 2014, filed 15 May 2014.